Antibodies come back from the brink.
Holliger
P
P
Hoogenboom
H
H
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000235:genetics* / Q000627:therapeutic use*; D001709:Biotechnology; D006801:Humans; D000922:Immunotoxins / Q000009:adverse effects / Q000235:genetics / Q000627:therapeutic use; D015202:Protein Engineering; D011993:Recombinant Fusion Proteins / Q000009:adverse effects / Q000235:genetics / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D011993:Recombinant Fusion Proteins